Evidence map›Paper›PMID 31146754›Full record

ArticleBMC medical informatics and decision making2019

How to measure temporal changes in care pathways for chronic diseases using health care registry data.

Eugenio Ventimiglia, Mieke Van Hemelrijck, Lars Lindhagen, Pär Stattin, Hans Garmo

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eugenio VentimigliaDivision of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0003-3654-1629
Mieke Van HemelrijckKing's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (Tour), 3rd Floor, Bermondsey Wing, Guy's Hospital, London, SE1 9RT, UK.
Lars LindhagenUppsala Clinical Research Center, Uppsala, Sweden.
Pär StattinDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Hans GarmoKing's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (Tour), 3rd Floor, Bermondsey Wing, Guy's Hospital, London, SE1 9RT, UK. hans.garmo@kcl.ac.uk.

Funding

Cancer Research UK
6 · The paper itself

Abstract

backgroundDisease trajectories for chronic diseases can span over several decades, with several time-dependent factors affecting treatment decisions. Thus, there is a need for long-term predictions of disease trajectories to inform patients and healthcare professionals on the long-term outcomes and provide information on the need of future health care. Here, we propose a state transition model to describe and predict disease trajectories up to 25 years after diagnosis in men with prostate cancer (PCa), as a proof of principle.

methodsStates, state transitions, and transition probabilities were identified and estimated in Prostate Cancer data Base of Sweden (PCBaSe

resultsPCBaSe

conclusionsWe developed a reliable and accurate simulation tool, PCBaSe

Indexed as

Models, TheoreticalAdultAgedAged, 80 and overChronic DiseaseComorbidityDatabases, FactualDelivery of Health CareHumansIncidenceMaleMiddle AgedProof of Concept StudyProstatic NeoplasmsRegistriesSwedenAgeingChronic diseaseProstate cancerState transition

Identifiers

PMID31146754
PMCPMC6543619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.